Global drugmakers continue to control over 60% of drug public procurements in Russia

The share of foreign pharmaceutical companies in the segment of public procurement in Russia reached 63%, the highest figure in the last six years, according to latest market statistics in Russia and local media, reports the Pharma Letter’s local correspondent.

Despite statements from many global drugmakers about a decrease of their activities in Russia, their share in the domestic public procurement market in the first seven months of this year increased by 6.7% compared to the same period in 2022 to 63.4%.

This data was provided by the analytics company DSM Group, according to which this is the highest figure in at least the last six years. In value terms, it amounts to 294 billion roubles ($3.06 billion). For comparison, in the January–July 2022 period, the share of foreign companies in the government order segment was 56.7% (313 billion roubles).